Molokanova, O.; Schoenig, K.; Weng, S. -Y. et al.
GENERATION AND CHARACTERIZATION OF A MYOFIBROBLASTS SPECIFIC CONDITIONAL Col3a1a-CreERT2 MOUSE MODEL TO STUDY LIVER FIBROSISJOURNAL OF HEPATOLOGY. Bd. 62. 2015 S. S470-S470
Relle, Manfred; Weinmann-Menke, Julia; Scorletti, Eva et al.
Genetics and novel aspects of therapies in systemic lupus erythematosusAUTOIMMUNITY REVIEWS. Bd. 14. H. 11. 2015 S. 1005-1018
Tomer, Yaron; Dolan, Lawrence M.; Kahaly, George et al.
Genome wide identification of new genes and pathways in patients with both autoimmune thyroiditis and type 1 diabetesJOURNAL OF AUTOIMMUNITY. Bd. 60. 2015 S. 32-39
Sommer, Lisa; Peiffer, Kai-Henrik; Dietz, Julia et al.
Genotype-Specific Prevalence and Importance of Naturally Occurring Precore-, Basal Core Promoter- and preS-Mutations in a Large European Study Cohort of Patients Chronically Infected with Hepatitis B VirusHEPATOLOGY. Bd. 62. 2015 S. 971A-971A
Steven, S.; Kopp, M.; Mikhed, Y. et al.
Glucagon-like peptide 1 (GLP1) improves disseminated intravasal coagulation (DIC) and vascular function in LPS-induced endotoxemiaEUROPEAN HEART JOURNAL. Bd. 36. 2015 S. 437-438
Hiromatsu, Yuji; Wall, Jack R.; Kahaly, George J. et al.
Graves' OrbitopathyINTERNATIONAL JOURNAL OF ENDOCRINOLOGY. 2015
Gehrke, Nadine; Woerns, Marcus A.; Alt, Yvonne et al.
Hepatocyte-specific overexpression of B cell leukemia-3 in mice suppresses chemically-induced hepatocarcinogenesisHEPATOLOGY. Bd. 62. 2015 S. 1158A-1158A
Baek, Jea-Hyun; Zeng, Rui; Weinmann-Menke, Julia et al.
IL-34 mediates acute kidney injury and worsens subsequent chronic kidney diseaseJOURNAL OF CLINICAL INVESTIGATION. Bd. 125. H. 8. 2015 S. 3198-3214
Weinmann-Menke, J.; Sollinger, D.; Schamberger, B. et al.
IL-34 MEDIATES ACUTE KIDNEY INJURY WORSENING SUBSEQUENT CHRONIC KIDNEY DISEASETRANSPLANT INTERNATIONAL. Bd. 28. 2015 S. 27-27
Modest, Dominik P.; Stintzing, Sebastian; von Weikersthal, Ludwig Fischer et al.
Impact of Subsequent Therapies on Outcome of the FIRE-3/AIO KRK0306 Trial: First-Line Therapy With FOLFIRI Plus Cetuximab or Bevacizumab in Patients With KRAS Wild-Type Tumors in Metastatic Colorectal CancerJOURNAL OF CLINICAL ONCOLOGY. Bd. 33. H. 32. 2015 S. 3718-+